▶ 調査レポート

梅毒イムノアッセイ診断の世界市場:製品別、技術別、エンドユーザー別

• 英文タイトル:Syphilis Immunoassay Diagnostics Market (Product: Analyzers, Kits & Reagents; Technology: ELISA, CLIA, Others; End User: Hospitals, Diagnostic Labs, Blood Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。梅毒イムノアッセイ診断の世界市場:製品別、技術別、エンドユーザー別 / Syphilis Immunoassay Diagnostics Market (Product: Analyzers, Kits & Reagents; Technology: ELISA, CLIA, Others; End User: Hospitals, Diagnostic Labs, Blood Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN055資料のイメージです。• レポートコード:TPM-2JN055
• 出版社/出版日:Transparency Market Research / 2019年12月30日
• レポート形態:英文、PDF、207ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥660,630 (USD5,795)▷ お問い合わせ
  Multi User¥1,002,630 (USD8,795)▷ お問い合わせ
  Corporate License¥1,344,630 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは梅毒イムノアッセイ診断の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、技術別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。
・序論
・仮定・研究方法
・エグゼクティブサマリー
・市場状況
・市場動向
・梅毒イムノアッセイ診断の世界市場:製品別
・梅毒イムノアッセイ診断の世界市場:技術別
・梅毒イムノアッセイ診断の世界市場:エンドユーザー別
・梅毒イムノアッセイ診断の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)
・梅毒イムノアッセイ診断の北米市場分析・予測
・梅毒イムノアッセイ診断の欧州市場分析・予測
・梅毒イムノアッセイ診断のアジア太平洋市場分析・予測
・梅毒イムノアッセイ診断の中南米市場分析・予測
・梅毒イムノアッセイ診断の中東・アフリカ市場分析・予測
・競争状況

New innovations in syphilis analyzers are becoming increasingly mainstream in the syphilis immunoassay diagnostics market. As such, companies are launching new technologies in analyzers. For instance, in April 2019, Gold Standard Diagnostics – a provider of comprehensive diagnostic solutions, revealed the launch of its proprietary technology with a U.S. patent, which performs serological testing for syphilis.

Advancements in analyzer technologies are creating incremental opportunities for healthcare companies in the syphilis immunoassay diagnostics market space. There is increasing demand for advanced analyzers in hospitals and blood banks due to increase in the spending capacity of patients with STDs. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes in patients.

Novel approaches of technological automation and machine learning are being adopted to develop first-of-its-kind diagnostics systems. The combination of approaches is helping clinical laboratories offer high-quality solutions for syphilis testing.

The growing trend of on-the-spot testing solutions has led to improvements in the syphilis immunoassay diagnostics landscape. For instance, clinical diagnostics company MBio, announced the launch of the LightDeck® platform, an innovative analytical technology that performs quantitative immunoassays and cell based assays. With the help of on-the-spot testing, companies in the syphilis immunoassay diagnostics market can tap into new business models, such as providing analytical testing services to the veterinary, food, military sectors.

Companies in the syphilis immunoassay diagnostics market are focused on expanding their product portfolios. They are increasing efforts to manufacture and sell instruments by acquiring licensing for the same. By these efforts, they are supporting the global OEM supply business model associated with various assays and their applications.

Healthcare industries are developing multiplexed immunoassay systems by experimenting on planar waveguide technology and fluorescence imaging. These efforts are being made to support outcomes in the ELISA (enzyme-linked immunosorbent assay) test, since ELISA currently accounts for the highest revenue in the syphilis immunoassay diagnostics market.

Recent advancements in molecular biology have led to the popularity of molecular diagnosis, such as the polymerase chain reaction (PCR), in the syphilis immunoassay diagnostics ecosystem. PCR technology is playing a crucial role in diagnosing syphilis. Healthcare industries in the syphilis immunoassay diagnostics market are developing various PCR methodologies that can be easily adapted in the clinical and laboratory environment. PCR is being increasingly associated with widespread application and deep exploration in the healthcare space.

Fast developments in PCR have led to advancements in real-time PCR, nested PCR, and multiplex PCR. The high sensitivity and specificity of PCR is well-suited for the diagnosis of early-stage syphilis. On the other hand, routine PCR is well-received in secondary syphilis. Healthcare companies in the syphilis immunoassay diagnostics market are increasing R&D to detect atypical cases of vertebral, ocular, and tonsillar syphilis with the help of molecular biology. Real-time PCR is gaining increased popularity for its ability to calculate the sum of pathogens that reveal the severity of the infection.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market

4. Market Overview

4.1. Introduction

4.1.1. Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Technological Advancement

5.2. Key Merger & Acquisition

5.3. Top Three Players- Analysis

5.4. Number of Syphilis Diagnostic Test, by Technology (2018)

5.5. Pricing Analysis by Technology

5.6. Disease Prevalence & Incidence Rate

6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product, 2017–2027

6.3.1. Analyzers

6.3.2. Kits & Reagents

6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product

7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017–2027

7.3.1. ELISA

7.3.2. CLIA

7.3.3. Others

7.4. Market Attractiveness, by Technology

8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Diagnostics Labs

8.3.3. Blood Banks

8.3.4. Others

8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user

9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region

10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

10.1. Introduction

10.1.1. Key Findings

10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027

10.2.1. Analyzers

10.2.2. Kits & Reagents

10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

10.3.1. ELISA

10.3.2. CLIA

10.3.3. Others

10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

10.4.1. Hospitals

10.4.2. Diagnostics Labs

10.4.3. Blood Banks

10.4.4. Others

10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Technology

10.6.3. By End-user

10.6.4. By Country

11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

11.1. Introduction

11.1.1. Key Finding

11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

11.2.1. Analyzers

11.2.2. Kits & Reagents

11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

11.3.1. ELISA

11.3.2. CLIA

11.3.3. Others

11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

11.4.1. Hospitals

11.4.2. Diagnostic Labs

11.4.3. Blood Banks

11.4.4. Others

11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Italy

11.5.5. Spain

11.5.6. Russia

11.5.7. Turkey

11.5.8. Eastern Europe

11.5.9. Rest of Europe

11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Technology

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

12.1. Introduction

12.1.1. Key Finding

12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

12.2.1. Analyzers

12.2.2. Kits & Reagents

12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

12.3.1. ELISA

12.3.2. CLIA

12.3.3. Others

12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

12.4.1. Hospitals

12.4.2. Diagnostic Labs

12.4.3. Blood Banks

12.4.4. Others

12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. South Korea

12.5.6. Vietnam

12.5.7. Rest of Asia Pacific

12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Technology

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

13.1. Introduction

13.1.1. Key Finding

13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

13.2.1. Analyzers

13.2.2. Kits & Reagents

13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

13.3.1. ELISA

13.3.2. CLIA

13.3.3. Others

13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

13.4.1. Hospitals

13.4.2. Diagnostic Labs

13.4.3. Blood Banks

13.4.4. Others

13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Rest of Latin America

13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Technology

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

14.1. Introduction

14.1.1. Key Finding

14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

14.2.1. Analyzers

14.2.2. Kits & Reagents

14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027

14.3.1. ELISA

14.3.2. CLIA

14.3.3. Others

14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027

14.4.1. Hospitals

14.4.2. Diagnostic Labs

14.4.3. Blood Banks

14.4.4. Others

14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Maghreb

14.5.4. Rest of Middle East & Africa

14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Technology

14.6.3. By End-users

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Market Share Analysis by Company (2018)

15.3. Company Profiles

15.3.1. F. Hoffmann-La Roche AG

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Bio-Rad Laboratories, Inc.

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. BD

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Siemens Healthineers AG

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. DiaSorin S.p.A.

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Abbott

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. bioMérieux SA

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Company Financials

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis

15.3.10. Fujirebio (Miraca Group) (Miraca Group)

15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.10.2. Company Financials

15.3.10.3. Growth Strategies

15.3.10.4. SWOT Analysis

15.3.11. Fujirebio (Miraca Group)

15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.11.2. Company Financials

15.3.11.3. Growth Strategies

15.3.11.4. SWOT Analysis

15.3.12. Danaher (Beckman Coulter, Inc.)

15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.12.2. Company Financials

15.3.12.3. Growth Strategies

15.3.12.4. SWOT Analysis

List of Tables

Table 01: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 02: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 04: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017 - 2027

Table 05: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017 - 2027

Table 06: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 07: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 08: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 09: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 10: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 11: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 12: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 13: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 14: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 15: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 16: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 17: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 18: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 19: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 20: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027

Table 21: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027

Table 22: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027

Table 23: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027

Table 24: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast,